---  
layout: startup_page  
title: "Mission Therapeutics"  
id: "missiontherapeutics.com"  
permalink: "/missiontherapeuticsmissiontherapeutics.com03142024/"  
website: "https://www.missiontherapeutics.com/"  
funding_round: ""  
funding_amount: "£25.2M"  
investors: "Pfizer Venture Investments, Sofinnova Partners, Roche Venture Fund, SR One, IP Group, Rosetta Capital"  
about: "Mission Therapeutics is a clinical-stage biotech company developing first-in-class therapeutics that enhance mitophagy to promote cell and organ health. Their lead drug candidates, MTX325 and MTX652, inhibit USP30 to increase mitochondrial ubiquitylation, improving cellular health and potentially treating diseases linked to dysfunctional mitochondria."  
markets: "Biotechnology, Pharmaceuticals, Healthtech, Oncology, Neurodegeneration"  
hq: "Cambridge, Cambridgeshire, United Kingdom"  
founded_year: "2011"  
linkedin: "https://uk.linkedin.com/company/mission-therapeutics"  
twitter: "https://twitter.com/MISSIONTherapeu"  
instagram: ""  
facebook: ""  
crunchbase: "https://www.crunchbase.com/organization/mission-therapeutics"  
pitchbook: "https://pitchbook.com/profiles/company/55213-39"  

date_display: "14-Mar-2024"  
date: "2024-03-14"

# SEO Optimization  
meta_title: "Mission Therapeutics -  Funding (£25.2M)"  
meta_description: "Mission Therapeutics, Mission Therapeutics is a clinical-stage biotech company developing first-in-class therapeutics that enhance mitophagy to promote cell and organ healt..."  
meta_keywords: "Mission Therapeutics, Biotechnology, Pharmaceuticals, Healthtech, Oncology, Neurodegeneration,  funding"  
canonical_url: "https://startup.projectstartups.com/missiontherapeuticsmissiontherapeutics.com03142024/"  
---